CB Insights
Technology Market Intelligence
Technology Market Intelligence
Calithera Biosciences, formerly Protein Activation Therapeutics, develops therapeutic approaches to the treatment of cancer by using small molecules to activate, rather than inhibit, enzymes. The company's first program is focused on developing activ...Show all
Company (IPO / Went public)
Phone: 650-870-1000
343 Oyster Point Blvd
Suite 200
South San Francisco, 94080
California, United States
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Heterocyclic inhibitors of glutaminase | Sep 11, 2017 | Apr 10, 2018 | Patent |
| Combination therapy with glutaminase inhibitors | Jun 12, 2015 | Jun 27, 2017 | Patent |
| Heterocyclic inhibitors of glutaminase | Oct 10, 2013 | Oct 21, 2014 | Patent |
| Heterocyclic inhibitors of glutaminase | Nov 19, 2012 | Dec 10, 2013 | Patent |
| Combination therapy with glutaminase inhibitors | May 03, 2017 | Application |
